Concepedia

Katarína Petráková

KP

Statistics

Publications

4

Citations

928

H-Index

4

Active since

2012

Affiliations

Institut de Cancérologie de l'Ouest(Current)

Novartis (United States)

Sarah Cannon

The University of Texas MD Anderson Cancer Center

Masaryk Memorial Cancer Institute

Katarína Petráková is an author at Institut de Cancérologie de l'Ouest specializing in oncology, breast oncology, and medicine.

Publications per year

2012–2018

4

Publications

4

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Gabriel N. Hortobágyi, Salomon M. Stemmer, H. A. Burris et al. · Annals of Oncology · 2018 · 868 citations · Full text

, , +17

Triple Negative Breast Cancer

Jiří Navrátil, Pavel Fabián, Markéta Palácová et al. · Klinicka onkologie · 2015 · 31 citations · Full text

, , +5

Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.

Francis P. Arena, Shinzaburo Noguchi, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 2012 · 16 citations

, , +17

Hereditary Breast and Ovarian Cancer Syndrome

Katarína Petráková, Markéta Palácová, Monika Schneiderová et al. · Klinicka onkologie · 2016 · 13 citations · Full text

, , +14

1–4 of 4